| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 12 | -1,282,250 | 100% | $194.03 | -$248,798,743 |
| Net | -12 | -1,282,250 | -100% | -$248,798,743 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Matthew Rabinowitz | EXECUTIVE CHAIRMAN, Director | $459,658,900 | -$36,216,676 | -7.3% | 04 Nov 2025 |
| ROELOF BOTHA | Director | $264,997,107 | -$17,708,936 | -6.3% | 30 Jan 2026 |
| JAMES HEALY | Director | $225,766,720 | 25 Apr 2025 | ||
| Jonathan Sheena | Director, CO-FOUNDER | $70,709,213 | -$17,993,394 | -20% | 03 Feb 2026 |
| DANIEL RABINOWITZ | Sec. And Chief Legal Officer | $52,015,820 | -$10,506,484 | -17% | 03 Feb 2026 |
| John Fesko | President, Chief Bus. Officer | $41,161,642 | -$6,933,764 | -14% | 03 Feb 2026 |
| Solomon Moshkevich | President, Clinicaldiagnostics | $31,810,676 | -$16,017,853 | -33% | 02 Feb 2026 |
| Steven Leonard Chapman | CEO AND PRESIDENT, Director | $31,015,227 | -$102,531,498 | -77% | 02 Feb 2026 |
| Michael Burkes Brophy | Chief Financial Officer | $12,743,785 | -$22,054,165 | -63% | 03 Feb 2026 |
| Robert Alan Schueren | Chief Operating Officer | $9,082,035 | 27 Jan 2023 | ||
| HERM ROSENMAN | Director | $4,682,828 | -$11,011,477 | -70% | 30 Jan 2026 |
| Roy D. Baynes | Director | $4,221,899 | -$2,809,689 | -40% | 30 Jan 2026 |
| Gail Boxer Marcus | Director | $1,548,587 | -$3,494,195 | -69% | 30 Jan 2026 |
| Rowan E. Chapman | Director | $1,345,674 | -$1,520,612 | -53% | 30 Jan 2026 |
| Brinkley Ruth Williams | Director | $1,234,566 | 30 Jan 2026 | ||
| Monica Bertagnolli | Director | $1,212,115 | 30 Jan 2026 | ||
| Todd C. Cozzens | Director | $1,038,936 | 25 May 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|